Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | SLC16A3 | O15427 | 9/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL27566515 | 0.83 | SMN1; SMN2 (0.52) | SMN1; SMN2SLC16A3TDP1L3MBTL1KMT2A | |
| SCHEMBL5657531 | 0.81 | SLC16A3 (0.46) | SLC16A3TDP1KMT2AMEN1PPARG | |
| SCHEMBL31661727 | 0.81 | SLC16A3 (0.46) | SLC16A3TDP1KMT2AMEN1PPARG | |
| SCHEMBL31661766 | 0.81 | SLC16A3 (0.54) | SLC16A3KMT2AMEN1PPARG | |
| SCHEMBL2229279 | 0.81 | SLC16A3 (0.54) | SLC16A3KMT2AMEN1PPARG | |
| SCHEMBL4955006 | 0.80 | PPARG (0.71) | SMN1; SMN2TDP1L3MBTL1PPARGNLRP3 | |
| SCHEMBL13814819 | 0.78 | SMN1; SMN2 (0.64) | SMN1; SMN2L3MBTL1KMT2AMEN1NLRP3 | |
| SCHEMBL3863550 | 0.78 | SMN1; SMN2 (0.57) | SMN1; SMN2SLC16A3TDP1L3MBTL1KMT2A | |
| SCHEMBL31661740 | 0.78 | LMNA (0.56) | SMN1; SMN2SLC16A3TDP1KMT2AMEN1 | |
| SCHEMBL28134891 | 0.78 | SLC16A3 (0.52) | SLC16A3TDP1KMT2AMEN1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | disclosed |